Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Zhendong Guangming Pharmaceutical Research Institute is the core research and development subsidiary of Shanxi Zhendong Pharmaceutical Group. Located in Beijing, the institute focuses on the development of innovative chemical drugs, high-end generic medications, and modernized traditional Chinese medicine (TCM). Its research portfolio spans multiple therapeutic areas, including oncology, gastroenterology, and cardiovascular health. The institute provides comprehensive drug discovery and development services, supporting the parent company's transition from a traditional manufacturer to an innovation-driven pharmaceutical leader. It operates advanced laboratories for synthesis, formulation, and pharmacological testing to maintain a competitive pipeline in the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Zhendong Guangming Pharmaceutical Research Institute.